DHTKD1 and neoplasm: Its mechanism of anti-tumour action is that a 24pb base deletion in the E1A gene that prevents it from binding the retinoblastoma tumour suppressor protein (Rb) protein and thus from replicating in normal tissues, whereas in Rb-deficient tumour cells, where E2F is in a free state, the virus can still replication (208).